Cochlear implants (CIs) are commonly used for profound bilateral hearing loss. They have specific national guidance for their insertion, however patients with a substantial residual acoustic hearing are potential CI candidates. Preservation of this residual hearing can be sought with...
TLM for glottic carcinoma has historically been performed with a carbon dioxide (CO2) laser. A much smaller literature base has examined the use of potassium titanyl phosphate (KTP) laser in this context. This retrospective chart review aims to fill that...
This article reminds readers of how often invasive thyroid disease can appear, as the symptomatology is minimal. Noticeable airway symptoms appear after 50% of the airway is involved and surgeons can often fall in the unsuspecting trap of discovering locally...
As otorhinolaryngologists, we are trained to examine the computed tomography (CT) scans of all patients with maxillary chronic rhinosinusitis (CRS) for potential dental disease. The mainstay of managing this is generally limited to referring the patient to their dentist or...
This paper divides the assessment up into anatomical (nasal and oropharyngeal), endoscopic and imaging. It points out the salient features to look out for in OSA patients with regards the nasal valve and also oropharyngeal anatomy, with tonsil hypertrophy grading...
British Tinnitus Association staff members, Colette Bunker, Angela Pollard and Jess Pollard, will be completing their first ever marathon on 3 October as they take on the Virgin Money Virtual London Marathon for the charity they work for. The British...
Soluvos Medical is proud to be an official partner for COOK OHNS in the BeNeLux region, as of 1 February 2022, for the COOK OHNS product line: Sialendoscopy, Biodesign Otologic repair, Doppler Blood Flow Monitor, Biodesign Dural repair.
Neuromod Devices Ltd., has reached an agreement with HØR AS, Norway’s largest private provider of hearing and tinnitus care, to make its Lenire tinnitus treatment device available in Norway.
The family-owned medical technology company KARL STORZ announces the acquisition of 100 percent of the shares of AventaMed DAC, an Irish medical technologies company.
Vestibular schwannoma is the commonest tumour of the cerebellopontine angle (80%) and accounts for around 8% of all intracranial tumours. The commonest primary presenting symptoms are audio vestibular. Hearing health professionals are often the first contact for patients with potential symptoms of vestibular schwannoma, with the majority then being seen and diagnosed by otorhinolaryngologists.